HYDROXYUREA for Myeloproliferative neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 162 adverse event reports in the FDA FAERS database where HYDROXYUREA was used for Myeloproliferative neoplasm.
Most Reported Side Effects for HYDROXYUREA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 519 | 8.7% | 63 | 189 |
| Anaemia | 358 | 6.0% | 50 | 188 |
| Drug ineffective | 356 | 6.0% | 81 | 103 |
| Fatigue | 291 | 4.9% | 11 | 94 |
| Thrombocytopenia | 253 | 4.2% | 38 | 149 |
| Nausea | 247 | 4.1% | 8 | 95 |
| Pyrexia | 243 | 4.1% | 37 | 161 |
| Diarrhoea | 222 | 3.7% | 19 | 101 |
| Febrile neutropenia | 202 | 3.4% | 25 | 107 |
| Intentional product use issue | 201 | 3.4% | 11 | 49 |
| Dyspnoea | 184 | 3.1% | 14 | 87 |
| Platelet count decreased | 175 | 2.9% | 27 | 70 |
| Platelet count increased | 174 | 2.9% | 3 | 44 |
| Headache | 173 | 2.9% | 5 | 68 |
| Skin ulcer | 173 | 2.9% | 7 | 60 |
Other Indications for HYDROXYUREA
Product used for unknown indication (1,619)
Essential thrombocythaemia (629)
Polycythaemia vera (552)
Chronic myeloid leukaemia (457)
Sickle cell disease (246)
Acute myeloid leukaemia (230)
Thrombocytosis (184)
Myelofibrosis (129)
Sickle cell anaemia (119)
Polycythaemia (118)
Other Drugs Used for Myeloproliferative neoplasm
RUXOLITINIB (2,982)
PACRITINIB (365)
LENALIDOMIDE (163)
FEDRATINIB (146)
AZACITIDINE (99)
VENETOCLAX (94)
PEGINTERFERON ALFA-2A (75)
IMATINIB (71)
THALIDOMIDE (56)
ROPEGINTERFERON ALFA-2B-NJFT (54)